Moreover, BRG1 suppressed neutrophil infiltration and modulated NO bioavailability in endothelial cells to inhibit cardiac ischemia–reperfusion injury in mice [28, 29]. This evidence concerns the gene SMARCA4 and myocardial ischemia.